Stericycle (NASDAQ:SRCL) Releases FY 2024 Earnings Guidance

Stericycle (NASDAQ:SRCL - Get Free Report) updated its FY 2024 earnings guidance on Thursday. The company provided EPS guidance of 2.200-2.500 for the period, compared to the consensus EPS estimate of 2.330. The company issued revenue guidance of -.

Analysts Set New Price Targets

Several equities research analysts have commented on the stock. Truist Financial increased their price objective on shares of Stericycle from $50.00 to $57.00 and gave the company a hold rating in a research note on Thursday, February 29th. Stifel Nicolaus increased their price objective on shares of Stericycle from $70.00 to $75.00 and gave the company a buy rating in a research note on Thursday, February 29th. Wells Fargo & Company increased their price objective on shares of Stericycle from $40.00 to $48.00 and gave the company an underweight rating in a research note on Friday, March 1st. Royal Bank of Canada reiterated an outperform rating and issued a $69.00 price objective on shares of Stericycle in a research note on Thursday, March 7th. Finally, StockNews.com lowered shares of Stericycle from a buy rating to a hold rating in a research note on Tuesday, April 2nd. One investment analyst has rated the stock with a sell rating, two have issued a hold rating and two have given a buy rating to the company. According to data from MarketBeat, Stericycle has an average rating of Hold and an average target price of $62.25.

Stericycle Stock Performance

Shares of Stericycle stock traded down $3.36 on Thursday, reaching $46.51. 1,151,666 shares of the company traded hands, compared to its average volume of 462,838. Stericycle has a 52 week low of $37.78 and a 52 week high of $57.06. The company has a 50 day moving average of $51.42 and a 200 day moving average of $48.15. The firm has a market capitalization of $4.32 billion, a PE ratio of -193.78, a PEG ratio of 2.71 and a beta of 1.09. The company has a debt-to-equity ratio of 0.51, a current ratio of 0.94 and a quick ratio of 0.94.

Stericycle (NASDAQ:SRCL - Get Free Report) last released its quarterly earnings data on Wednesday, February 28th. The business services provider reported $0.54 EPS for the quarter, topping the consensus estimate of $0.47 by $0.07. The company had revenue of $652.00 million during the quarter, compared to the consensus estimate of $657.99 million. Stericycle had a negative net margin of 0.80% and a positive return on equity of 7.06%. Stericycle's revenue for the quarter was down 2.7% on a year-over-year basis. During the same period last year, the firm earned $0.60 EPS. Equities analysts forecast that Stericycle will post 2.32 earnings per share for the current year.

Stericycle Company Profile

Stericycle, Inc, together with its subsidiaries, provides regulated waste and compliance services in the United States, Europe, and internationally. The company offers regulated waste and compliance services, including regulated medical waste, sharps waste management and disposal, pharmaceutical waste management and disposal, chemotherapy waste and disposal, controlled substance waste disposal, healthcare hazardous waste, and integrated waste stream solutions; specialty services, such as MedDrop medication collection kiosks, safe community solutions, SafeDrop sharps mailback solutions, and airport and maritime waste services; medical supply store services, that includes sharps and disposable biohazardous waste containers, infection control supplies, and seal&send medication mail back; and compliance solutions including Steri-Safe compliance solutions.